Italia markets closed

Global Blood Therapeutics, Inc. (GBT)

NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
66,75+0,18 (+0,27%)
Alla chiusura: 04:00PM EDT
66,72 -0,03 (-0,04%)
Dopo ore: 07:45PM EDT
Schermo intero
I prezzi di scambio non provengono da tutti i mercati
Chiusura precedente66,57
Aperto66,67
Denaro66,57 x 800
Lettera66,74 x 800
Min-Max giorno66,59 - 66,81
Intervallo di 52 settimane21,65 - 73,02
Volume5.756.240
Media Volume2.664.188
Capitalizzazione4,503B
Beta (5 anni mensile)0,83
Rapporto PE (ttm)N/D
EPS (ttm)-4,86
Prossima data utili02 nov 2022 - 07 nov 2022
Rendimento e dividendo (forward)N/D (N/D)
Data ex dividendoN/D
Stima target 1A66,63
  • GlobeNewswire

    Pfizer to Acquire Global Blood Therapeutics for $5.4 Billion to Enhance Presence in Rare Hematology

    Proposed acquisition drives growth by bringing leading sickle cell disease expertise, portfolio and pipeline to Pfizer with potential combined worldwide peak sales of more than $3 billion Potential to address the full spectrum of critical needs in the underserved sickle cell community Transaction valued at $68.50 per Global Blood Therapeutics share in cash, for a total enterprise value of approximately $5.4 billion NEW YORK and SOUTH SAN FRANCISCO, Calif., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Pfize

  • GlobeNewswire

    GBT Announces New Employment Inducement Grants

    SOUTH SAN FRANCISCO, Calif., Aug. 04, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that on August 1, 2022, the compensation committee of GBT’s board of directors granted 10 new employees restricted stock units for an aggregate of 30,450 shares of the company’s common stock. These awards were made under GBT’s Amended and Restated 2017 Inducement Equity Plan (the Plan). The above-described awards were each granted as an inducement material to the emp

  • GlobeNewswire

    GBT Announces Participation at the Wedbush PacGrow Healthcare Conference

    SOUTH SAN FRANCISCO, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will participate in a virtual fireside chat at the Wedbush PacGrow Healthcare Conference on Wednesday, August 10, 2022, at 2:20 p.m. E.T. The fireside chat will be webcast live from GBT’s website at www.gbt.com in the Investors section. A replay of the webcast will be archived and available for one month following the event. About Global Blood Therapeutics Gl